Hugues Sanke-Waïgana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hugues Sanke-Waïgana has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Manirakiza
Institut Pasteur of Bangui, Pasteur International Network
2 shared publications - Yakhya Dieye
Pôle de Microbiologie, Institut Pasteur de Dakar, Dakar BP 220, Senegal
2 shared publications Alioune Dieye
Cheikh Anta Diop University of Dakar
1 shared publication- Alioune Dieye
Department of Immunology, Faculty of Medicine and Pharmacy, Cheikh Anta Diop University, Dakar 10700, Senegal
1 shared publication - Benoit S. Marteyn
Université de Strasbourg, Institut de Biologie Moléculaire et Cellulaire (IBMC), CNRS UPR9002, 67000 Strasbourg, France
1 shared publication Brice Martial Yambiyo
Institut Pasteur de Bangui
1 shared publication
Latest Publications
- Open Access
High Fecal Carriage of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae by Children Admitted to the Pediatric University Hospital Complex in Bangui, Central African Republic
Antimicrobial resistance (AMR) is a global public health threat. Quality data on AMR are needed to tackle the rise of multidrug-resistant clones. These data are rare in low-income countries, especially in sub-Saharan Africa. In this study, we investigated the rise of extended-spectrum β-lactamase–producing (ESBL) Enterobacteriaceae in Bangui, Central African Republic. We collected 278 fecal samples from 0–5-year-old children admitted to the Pediatric University Hospital Complex in Bangui from July to September 2021. Enterobacteriaceae were isolated and identified, and their susceptibility to 19 antibiotics was tested. We recovered one and two Enterobacteriaceae species from 208 and 29 samples, respectively. One clone of each species from each sample was further characterized, for a total of 266 isolates. Escherichia coli predominated, followed by Klebsiella. AMR was frequent, with 98.5% (262/266) of the isolates resistant to at least one antibiotic. Additionally, 89.5% (238/266) of the isolates were multidrug resistant, with resistance being frequent against all tested antibiotics except carbapenems and tigecycline, for which no resistance was found. Importantly, 71.2% (198/278) of the children carried at least one ESBL species, and 85.3% (227/266) of the isolates displayed this phenotype. This study confirms the rise of ESBL Enterobacteriaceae in Bangui and stresses the need for action to preserve the efficacy of antibiotics, as crucial for the treatment of bacterial infections.
Open AccessHigh Fecal Carriage of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae by Children Admitted to the Pediatric University Hospital Complex in Bangui, Central African Republic
Antimicrobial resistance (AMR) is a global public health threat. Quality data on AMR are needed to tackle the rise of multidrug-resistant clones. These data are rare in low-income countries, especially in sub-Saharan Africa. In this study, we investigated the rise of extended-spectrum β-lactamase–producing (ESBL) Enterobacteriaceae in Bangui, Central African Republic. We collected 278 fecal samples from 0–5-year-old children admitted to the Pediatric University Hospital Complex in Bangui from July to September 2021. Enterobacteriaceae were isolated and identified, and their susceptibility to 19 antibiotics was tested. We recovered one and two Enterobacteriaceae species from 208 and 29 samples, respectively. One clone of each species from each sample was further characterized, for a total of 266 isolates. Escherichia coli predominated, followed by Klebsiella. AMR was frequent, with 98.5% (262/266) of the isolates resistant to at least one antibiotic. Additionally, 89.5% (238/266) of the isolates were multidrug resistant, with resistance being frequent against all tested antibiotics except carbapenems and tigecycline, for which no resistance was found. Importantly, 71.2% (198/278) of the children carried at least one ESBL species, and 85.3% (227/266) of the isolates displayed this phenotype. This study confirms the rise of ESBL Enterobacteriaceae in Bangui and stresses the need for action to preserve the efficacy of antibiotics, as crucial for the treatment of bacterial infections.
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
High Fecal Carriage of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae by Children Admitted at the Pediatric University Hospital Complex in Bangui, Central African Republic
Background: Antimicrobial resistance (AMR) has become a global public health threat. Quality data on AMR are needed to tackle the rise of multidrug resistant clones globally. These data are rare in low-and-middle-income countries, especially in sub-Saharan Africa. In this study, we aimed to investigate on the rise of extended-spectrum β-lactamase-producing (ESBL) enterobacteriaceae in Bangui, Central African Republic. Methods: We collected 278 fecal samples from 0-5 year-old children admitted at the Pediatric University Hospital Complex in Bangui, from July to September 2021. Bacteria were isolated on BCP and CHROMagar ESBL plates, and identified using API galleries. Susceptibility to 19 antibiotics belonging to seven classes was tested using disc diffusion method and interpreted according to EUCAST 2021 guidelines. Results: We isolated one and two enterobacteriaceae species from 208 and 29 samples respectively, for a total of 266 strains. Escherichia coli predominated followed by Klebsiella . AMR was frequent with 98.5% (262/266) of the isolates resistant to one antibiotic at least. Of these isolates, 89.5% (238/266) were multidrug resistant, resistance being frequent against all the tested classes except carbapenems and tigecycline for which no resistance was found. Importantly, 71.2% of the children carried at least one ESBL species and 85.3% (227/266) of the isolates displayed this phenotype. Conclusion: This study confirms the rise of ESBL enterobacteriaceae in Bangui and stresses the need of an active surveillance and to monitor the use of antimicrobials in both hospital and community settings in order to preserve the efficacy of antibiotics crucial for treatment of bacterial infections.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessHigh Fecal Carriage of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae by Children Admitted at the Pediatric University Hospital Complex in Bangui, Central African Republic
Background: Antimicrobial resistance (AMR) has become a global public health threat. Quality data on AMR are needed to tackle the rise of multidrug resistant clones globally. These data are rare in low-and-middle-income countries, especially in sub-Saharan Africa. In this study, we aimed to investigate on the rise of extended-spectrum β-lactamase-producing (ESBL) enterobacteriaceae in Bangui, Central African Republic. Methods: We collected 278 fecal samples from 0-5 year-old children admitted at the Pediatric University Hospital Complex in Bangui, from July to September 2021. Bacteria were isolated on BCP and CHROMagar ESBL plates, and identified using API galleries. Susceptibility to 19 antibiotics belonging to seven classes was tested using disc diffusion method and interpreted according to EUCAST 2021 guidelines. Results: We isolated one and two enterobacteriaceae species from 208 and 29 samples respectively, for a total of 266 strains. Escherichia coli predominated followed by Klebsiella . AMR was frequent with 98.5% (262/266) of the isolates resistant to one antibiotic at least. Of these isolates, 89.5% (238/266) were multidrug resistant, resistance being frequent against all the tested classes except carbapenems and tigecycline for which no resistance was found. Importantly, 71.2% of the children carried at least one ESBL species and 85.3% (227/266) of the isolates displayed this phenotype. Conclusion: This study confirms the rise of ESBL enterobacteriaceae in Bangui and stresses the need of an active surveillance and to monitor the use of antimicrobials in both hospital and community settings in order to preserve the efficacy of antibiotics crucial for treatment of bacterial infections.
- Open Access
- 17 June 2021
- Published by Wiley in Maternal & Child Nutrition
- Vol. 17 (4) , e13215
Vitamin C levels in a Central‐African mother–infant cohort: Does hypovitaminosis C increase the risk of enteric infections?
In the MITICA (Mother‐to‐Infant TransmIssion of microbiota in Central‐Africa) study, 48 mothers and their 50 infants were followed from delivery to 6 months between December 2017 and June 2019 in Bangui (Central‐African Republic). Blood tests and stool analyses were performed in mothers at delivery, and their offspring at birth, 11 weeks and 25 weeks. Stool cultures were performed in specific growth media for Salmonella, Shigella, E. coli, Campylobacter, Enerobacter, Vibrio cholerae, Citrobacter and Klebsiella, as well as rotavirus, yeasts and parasitological exams. The median vitamin C levels in mothers at delivery were 15.3 μmol/L (inter‐quartile‐range [IQR] 6.2–27.8 μmol/L). In infants, the median vitamin C levels at birth were 35.2 μmol/L (IQR 16.5–63.9 μmol/L). At 11 and 25 weeks, the median vitamin C levels were 41.5 μmol/L (IQR 18.7–71.6 μmol/L) and 18.2 μmol/L (IQR 2.3–46.6 μmol/L), respectively. Hypovitaminosis C was defined as seric vitamin C levels P value = 0.002), and infants had significantly higher levels of vitamin C (median = 35.2 μmol/L; IQR 16.5–63.9 μmol/L), compared to mothers (median = 15.3 μmol/L; IQR 6.2–27.8 μmol/L; P value P value P value = 0.038).
- 17 June 2021
- Published by Wiley in Maternal & Child Nutrition
- Vol. 17 (4) , e13215
Open AccessVitamin C levels in a Central‐African mother–infant cohort: Does hypovitaminosis C increase the risk of enteric infections?
In the MITICA (Mother‐to‐Infant TransmIssion of microbiota in Central‐Africa) study, 48 mothers and their 50 infants were followed from delivery to 6 months between December 2017 and June 2019 in Bangui (Central‐African Republic). Blood tests and stool analyses were performed in mothers at delivery, and their offspring at birth, 11 weeks and 25 weeks. Stool cultures were performed in specific growth media for Salmonella, Shigella, E. coli, Campylobacter, Enerobacter, Vibrio cholerae, Citrobacter and Klebsiella, as well as rotavirus, yeasts and parasitological exams. The median vitamin C levels in mothers at delivery were 15.3 μmol/L (inter‐quartile‐range [IQR] 6.2–27.8 μmol/L). In infants, the median vitamin C levels at birth were 35.2 μmol/L (IQR 16.5–63.9 μmol/L). At 11 and 25 weeks, the median vitamin C levels were 41.5 μmol/L (IQR 18.7–71.6 μmol/L) and 18.2 μmol/L (IQR 2.3–46.6 μmol/L), respectively. Hypovitaminosis C was defined as seric vitamin C levels P value = 0.002), and infants had significantly higher levels of vitamin C (median = 35.2 μmol/L; IQR 16.5–63.9 μmol/L), compared to mothers (median = 15.3 μmol/L; IQR 6.2–27.8 μmol/L; P value P value P value = 0.038).